Ilan Neugarten

Ilan Neugarten is a senior executive at BlueWind Medical and a Tel Aviv-based solo angel writing $100k-$250k checks at pre-seed and seed in medical devices, with no AI flag. The narrow device focus and BlueWind operating affiliation make him a credible and domain-specialist angel for the Israeli medical device ecosystem, particularly for founders working in implantables, neuromodulation, and device-and-procedure plays adjacent to BlueWind’s space. Founders building Israeli medical devices, implantables, neuromodulation, or device-software hybrids where his device-operator pattern recognition adds meaningful technical and regulatory value are the natural fit. He is the wrong audience for digital health software, biotech, consumer wellness, AI-only plays, or anything outside the device-engineering stack. The check size is meaningful for an Israeli pre-seed device round and brings real operator signal. Outreach via LinkedIn is the primary channel; warm introductions through the Israeli MedTech community (BlueWind, Insightec, Trig MedTech, and the broader Tel Aviv device cluster) materially outperform cold notes. Without a website, Twitter, or published personal thesis, founders should rely on his BlueWind operating context as the primary signal of taste. Best treated as a domain-specialist Israeli MedTech angel for early-stage device founders with credible technical depth and a clear regulatory pathway.